amantadine has been researched along with Middle Ear Inflammation in 2 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Currently, annual influenza immunization is recommended for all children 6 months and older with high-risk conditions." | 2.41 | Reduction of the influenza burden in children. ( , 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertot, GM | 1 |
| Becker, PD | 1 |
| Guzmán, CA | 1 |
| Grinstein, S | 1 |
1 review available for amantadine and Middle Ear Inflammation
| Article | Year |
|---|---|
Reduction of the influenza burden in children.
Topics: Adolescent; Adult; Amantadine; Child; Comorbidity; Cost of Illness; Evidence-Based Medicine; Female; | 2002 |
1 other study available for amantadine and Middle Ear Inflammation
| Article | Year |
|---|---|
Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Amantadine; Animals; Antibodies, Bacterial; Bact | 2004 |